LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis
Article Abstract:
A study reveals that blocking LINGO-1 function in mice caused by Lingo1 knockout or treatment with anti-LINGO-1 promotes functional recovery associated with myeline oligodendrocyte glycoprotein (MOG)-induced (EAE) experimental autoimmune encephalomyelitis.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Bone cancer gain without the pain
Article Abstract:
Research on osteoprotegerin (OPG) may be effective in treating pain from primary or metastatic bone cancer. This soluble form of tumor necrosis factor binds to the OPG ligand, preventing osteolytic activity.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Life-sustaining therapy: a model for appropriate use. Medical education and financial assistance programs sponsored by US government agencies
- Abstracts: Physicians and the animal-rights movement. Placing Religion and Spirituality in End-of-Life Care. Should physicians prescribe religious activities?
- Abstracts: Sniffing out new approaches to spinal cord repair. Easing the brakes on spinal cord repair. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord
- Abstracts: Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates
- Abstracts: Penicillins and staphylococci: a historical interaction. New FDA Approvals. Linezolid (Zyvox)